A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Two-arm Safety and Efficacy Study of SYN118 as Adjunctive Therapy in Subjects with Parkinson?s Disease A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Two-arm Safety and Eff ...
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Two-arm Safety and Efficacy Study of SYN118 as Adjunctive Therapy in Subjects with Parkinson?s Disease A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Two-arm Safety and Eff ...
Parkinson´s disease inadequately controlled on a stable regimen of anti-Parkinsonian medications. MedDRA version: 12.0;Level: LLT;Classification code 10013113;Term: Disease Parkinson's Parkinson´s disease inadequately controlled on a stable regimen of anti-Parkinsonian medications. Me ...
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Two-arm Safety and Efficacy Study of SYN118 as Adjunctive Therapy in Subjects with Parkinson?s Disease A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Two-arm Safety and Eff ...
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Two-arm Safety and Efficacy Study of SYN118 as Adjunctive Therapy in Subjects with Parkinson?s Disease A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Two-arm Safety and Eff ...
Parkinson´s disease inadequately controlled on a stable regimen of anti-Parkinsonian medications. MedDRA version: 12.0;Level: LLT;Classification code 10013113;Term: Disease Parkinson's Parkinson´s disease inadequately controlled on a stable regimen of anti-Parkinsonian medications. Me ...